RESUMO
INTRODUCTION: Several studies conducted in African countries reported the artesunate and amodiaquine (AS/AQ) tablet as a safe and well-tolerated anti-malarial drug in children and younger adults. The aim of this case series assessment was to assess the causal relationship between the AS/AQ tablet and extrapyramidal reactions in children and younger adults and to investigate the factor(s) predisposing to the adverse drug reactions. METHODS: The causal relationship of all the cases was first assessed individually using the Naranjo Probability Scale and then subjected to a case series assessment using Austin Bradford-Hill criteria. RESULTS: A total of 43 acute extrapyramidal reactions associated with the AS/AQ tablet were reported between 2012 and 16 November, 2015 to the Eritrean Pharmacovigilance Centre. The causality was found to be probable or highly probable for 33 (76.7 %) of the cases and the rest (10; 23.3 %) of the cases had a possible causal association. The extrapyramidal reactions had more or less similar clinical features in most of the cases and were characterized by abnormal involuntary contractions of muscles. The median age and body weight of the cases were 15 years and 40 kg, respectively, and 70 % of them were males. 90.7% of the reactions manifested in children and younger adults (aged <26 years). In most of the cases, reactions manifested in the third day from the start of treatment and 88.3 % of cases were hospitalized. CONCLUSION: The causal relationship between the AS/AQ tablet and extrapyramidal reactions in children and younger adults was found to be apparent and possibly owing to dose accumulation or an overdose of amodiaquine.
Assuntos
Amodiaquina/efeitos adversos , Antimaláricos/efeitos adversos , Artemisininas/efeitos adversos , Doenças dos Gânglios da Base/induzido quimicamente , Hospitalização/estatística & dados numéricos , Adolescente , Adulto , Fatores Etários , Amodiaquina/administração & dosagem , Antimaláricos/administração & dosagem , Artemisininas/administração & dosagem , Doenças dos Gânglios da Base/fisiopatologia , Criança , Relação Dose-Resposta a Droga , Combinação de Medicamentos , Overdose de Drogas/epidemiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Farmacovigilância , Fatores de Tempo , Adulto JovemRESUMO
Little is known how electroconvulsive therapy (ECT) affects cognitive functions in subjects with schizophrenia. Assessment of cognitive functions in subjects with schizophrenia treated with ECT was performed using CNS Vital Signs computerized battery of tests. Thirteen patients treated with ECT plus antipsychotics were assessed before and after 12 to 15 bilateral ECT sessions. We did not find any important changes between pre-ECT and post-ECT cognitive performance. We also found that CNS Vital Signs is a useful computerized battery test for assessing cognitive functions of subjects treated with ECT.
Assuntos
Sistema Nervoso Central/fisiopatologia , Cognição/fisiologia , Eletroconvulsoterapia/métodos , Desempenho Psicomotor/fisiologia , Esquizofrenia/fisiopatologia , Psicologia do Esquizofrênico , Adulto , Doenças dos Gânglios da Base/fisiopatologia , Doenças dos Gânglios da Base/psicologia , Feminino , Humanos , Masculino , Testes Neuropsicológicos , Esquizofrenia Paranoide/psicologia , Esquizofrenia Paranoide/terapia , Sinais VitaisRESUMO
Research into therapeutics for neuropsychiatric disorders is increasingly focusing on drugs with new mechanisms of action, and such agents are often assessed in preclinical studies using nonhuman primates. However, researchers lack a standardised method to compare different drugs for common adverse effects on the nervous system. We have developed a new scale for this purpose, named "Drug Effects on the Nervous System" (DENS), and tested its utility in an analysis of the second-generation antipsychotic risperidone in monkeys. The behavioural effects of risperidone over a ten-fold clinically relevant exposure range were rated with the DENS scale and compared with a standard motor disability scale for primates. The ratings were correlated with projected D2 and 5-HT2A receptor occupancies over time. The DENS scale detected dose-dependent side effects of risperidone in addition to the motor effects detected with the motor disability scale, including cognitive, sensorimotor and autonomic functions. A consistent temporal association between the DENS scale changes and the projected D2 receptor occupancy was observed, and the DENS scale ratings demonstrated high inter-rater reliability. These results demonstrate the usefulness of the DENS scale as a highly sensitive, reliable and accurate method to identify common adverse effects of risperidone and potentially other neurotropics for translational studies in primates.
Assuntos
Sistema Nervoso/efeitos dos fármacos , Psicotrópicos/efeitos adversos , Algoritmos , Animais , Antipsicóticos/efeitos adversos , Antipsicóticos/metabolismo , Antipsicóticos/farmacocinética , Sistema Nervoso Autônomo/efeitos dos fármacos , Doenças dos Gânglios da Base/fisiopatologia , Comportamento Animal/efeitos dos fármacos , Córtex Cerebral/efeitos dos fármacos , Discinesia Induzida por Medicamentos/fisiopatologia , Feminino , Macaca fascicularis , Macaca mulatta , Masculino , Variações Dependentes do Observador , Psicotrópicos/metabolismo , Psicotrópicos/farmacocinética , Receptores de Droga/metabolismo , Padrões de Referência , Risperidona/efeitos adversos , Risperidona/metabolismo , Risperidona/farmacocinéticaRESUMO
Reactive astrocytosis seems to be strongly implicated in the development and maintenance of inflammatory and neurodegenerative disorders. We design a new toxic model treatment with 3-nitropropionic acid (3-NP), a mitochondrial complex II irreversible inhibitor, to induce in rats Huntington's disease (HD) like syndrome, characterized by hindlimb dystonia, involuntary choreiform movements and reduced global activity. In an attempt to find out whether molecular and morphological changes in the neuro-glial network could be involved in the pathogenesis of this disease, we developed a protocol of subchronic intra-peritoneal 3-NP intoxication. Moreover we set up specific, highly discriminative, behavioral tests to detect very early mild motor disabilities in 3-NP treated rats. This treatment did not cause severe cell death. However, in the Caudate-Putamen (CPu) of all 3-NP treated animals we found a massive astrogliosis, revealed by increased GFAP levels, paralleled by changes of the glial glutamate transporter GLAST distribution. To these glial changes we detected a transcriptional upregulation of c-fos and Sub-P in the striatal medium spiny neurons (MSN). We propose that this model of 3-NP intoxication along with the designed set of behavioral analyses allow to unmask in a very early phase the motor deficits and the underlying morpho-molecular changes associated to the onset of motor disabilities in the HD-like syndrome. Therefore this model unveil the key role played by the different components of the tripartite synapse in the pathogenesis of the HD, a putative non-cell-autonomous disease.
Assuntos
Astrócitos/patologia , Doenças dos Gânglios da Base/patologia , Gânglios da Base/patologia , Gliose/patologia , Neurotoxinas/toxicidade , Nitrocompostos/toxicidade , Propionatos/toxicidade , Animais , Astrócitos/efeitos dos fármacos , Astrócitos/metabolismo , Gânglios da Base/metabolismo , Gânglios da Base/fisiopatologia , Doenças dos Gânglios da Base/induzido quimicamente , Doenças dos Gânglios da Base/fisiopatologia , Comportamento Animal/fisiologia , Avaliação da Deficiência , Modelos Animais de Doenças , Transportador 1 de Aminoácido Excitatório/efeitos dos fármacos , Transportador 1 de Aminoácido Excitatório/metabolismo , Proteína Glial Fibrilar Ácida/efeitos dos fármacos , Proteína Glial Fibrilar Ácida/metabolismo , Gliose/induzido quimicamente , Gliose/fisiopatologia , Doença de Huntington/metabolismo , Doença de Huntington/patologia , Doença de Huntington/fisiopatologia , Masculino , Transtornos dos Movimentos/diagnóstico , Transtornos dos Movimentos/patologia , Transtornos dos Movimentos/fisiopatologia , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Neurônios/patologia , Testes Neuropsicológicos , Proteínas Proto-Oncogênicas c-fos/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-fos/metabolismo , Ratos , Ratos Sprague-Dawley , Índice de Gravidade de Doença , Substância P/efeitos dos fármacos , Substância P/metabolismo , Transmissão Sináptica/efeitos dos fármacos , Transmissão Sináptica/fisiologia , Fatores de TempoRESUMO
OBJECTIVE: To investigate the clinical features of autopsy-proven corticobasal degeneration (CBD). METHODS: We evaluated symptoms, signs, and neuropsychological deficits longitudinally in 15 patients with autopsy-proven CBD and related these observations directly to the neuroanatomic distribution of disease. RESULTS: At presentation, a specific pattern of cognitive impairment was evident, whereas an extrapyramidal motor abnormality was present in less than half of the patients. Follow-up examination revealed persistent impairment of apraxia and executive functioning, worsening language performance, and preserved memory. The motor disorder emerged and worsened as the condition progressed. Statistical analysis associated cognitive deficits with tau-immunoreactive pathology that is significantly more prominent in frontal and parietal cortices and the basal ganglia than temporal neocortex and the hippocampus. CONCLUSION: The clinical diagnosis of corticobasal degeneration should depend on a specific pattern of impaired cognition as well as an extrapyramidal motor disorder, reflecting the neuroanatomic distribution of disease in frontal and parietal cortices and the basal ganglia.
Assuntos
Encéfalo/fisiopatologia , Transtornos Cognitivos/diagnóstico , Transtornos dos Movimentos/diagnóstico , Doenças Neurodegenerativas/diagnóstico , Tauopatias/diagnóstico , Idade de Início , Idoso , Apraxias/diagnóstico , Apraxias/etiologia , Apraxias/fisiopatologia , Doenças dos Gânglios da Base/diagnóstico , Doenças dos Gânglios da Base/etiologia , Doenças dos Gânglios da Base/fisiopatologia , Encéfalo/patologia , Transtornos Cognitivos/etiologia , Transtornos Cognitivos/fisiopatologia , Progressão da Doença , Feminino , Humanos , Transtornos da Linguagem/diagnóstico , Transtornos da Linguagem/etiologia , Transtornos da Linguagem/fisiopatologia , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Transtornos dos Movimentos/etiologia , Transtornos dos Movimentos/fisiopatologia , Vias Neurais/patologia , Vias Neurais/fisiopatologia , Doenças Neurodegenerativas/fisiopatologia , Doenças Neurodegenerativas/psicologia , Emaranhados Neurofibrilares/metabolismo , Emaranhados Neurofibrilares/patologia , Exame Neurológico , Testes Neuropsicológicos , Valor Preditivo dos Testes , Sistema de Registros , Tauopatias/fisiopatologia , Tauopatias/psicologia , Proteínas tau/metabolismoRESUMO
The aim of the present study was to evaluate the role of primitive reflexes (PRs) as additional alert sign in routine clinical practice in patients with extrapyramidal syndrome. We considered glabellar, snout, palmomental and grasp reflexes in patients with mild stage of Lewy body dementia (LBD), corticobasal degeneration, progressive supranuclear palsy or Parkinson disease (PD). We also enrolled mild Alzheimer disease (AD) patients, and healthy subjects, as controls. LBD patients showed the highest prevalence of PRs compared with the other groups. The odds ratio of the risk of LBD in PRs > or = 2 was 27.9 (95% CI 2.9-269.0) compared with control group, 14.6 (95% CI 2.7-79.6) compared with mild AD, and 19.7 (95% CI 3.7-104.3) compared with PD. These data suggest that the occurrence of combination of PRs might be an useful additional warning sign of possible diffuse Lewy body pathology more than other causes of extrapyramidal syndrome.
Assuntos
Doenças dos Gânglios da Base/diagnóstico , Doenças dos Gânglios da Base/fisiopatologia , Reflexo Anormal/fisiologia , Idoso , Idoso de 80 Anos ou mais , Doenças dos Gânglios da Base/classificação , Estudos de Casos e Controles , Intervalos de Confiança , Feminino , Humanos , Masculino , Exame Neurológico , Exame FísicoRESUMO
BACKGROUND: Motor signs (MOSIs) are common in Alzheimer disease (AD) and may be associated with rates of cognitive decline, mortality, and cost of care. OBJECTIVE: To describe the progression and identify predictors of individual MOSIs in AD. METHODS: A cohort of 474 patients with AD at early stages was followed semiannually for up to 13.1 years (mean 3.6 years) in five centers in Europe and the United States. MOSIs were rated using a standardized portion of the Unified Parkinson's Disease Rating Scale. Overall, 3,030 visits/assessments of MOSIs (average 6.4/patient) were performed. Prevalence and incidence rates were calculated, and cumulative risk graphs were plotted for individual non-drug-induced MOSI domains. Rates of change over time taking into account potential covariates were also estimated. With use of each MOSI domain as outcome in Cox models, predictors of MOSI incidence were identified. RESULTS: At least one MOSI was detected in 13% of patients at first examination and in 36% for the last evaluation. Total MOSI score increased at an annual rate of 3% of total possible score. Rates of annual change for speech/facial expression (4%), rigidity (2.45%), posture/gait (3.9%), and bradykinesia (3.75%) were of similar magnitude, and their occurrence increased from first (3 to 6%) to last (22 to 29%) evaluation. Tremor was less frequent throughout the course of the disease (4% at first and 7% at last evaluation) and worsened less (0.75% increase/year). CONCLUSIONS: Most motor signs occur frequently and progress rapidly in Alzheimer disease. Tremor is an exception in that it occurs less frequently and advances at slower rates.
Assuntos
Doença de Alzheimer/complicações , Transtornos dos Movimentos/etiologia , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/economia , Doença de Alzheimer/genética , Doença de Alzheimer/fisiopatologia , Apolipoproteínas E/genética , Doenças dos Gânglios da Base/epidemiologia , Doenças dos Gânglios da Base/etiologia , Doenças dos Gânglios da Base/fisiopatologia , Estudos de Coortes , Progressão da Doença , Europa (Continente)/epidemiologia , Tratos Extrapiramidais/fisiopatologia , Expressão Facial , Feminino , Seguimentos , Humanos , Hipocinesia/epidemiologia , Hipocinesia/etiologia , Incidência , Masculino , Pessoa de Meia-Idade , Transtornos dos Movimentos/economia , Transtornos dos Movimentos/epidemiologia , Prevalência , Modelos de Riscos Proporcionais , Índice de Gravidade de Doença , Tremor/epidemiologia , Tremor/etiologia , Estados Unidos/epidemiologiaRESUMO
Many patients who receive antipsychotic medications experience dystonia, akinesia, dyskinesia, and akathisia, collectively called Extrapyramidal Symptom Side Effects (EPS). The purpose of this study was to establish interrater reliability for a Nursing EPS Assessment Scale developed to focus on all four symptom areas. Twenty RNs and 12 patients participated in the instrument development studies. After several revisions, interrater reliability significance was demonstrated at the 0.01 level. It was concluded that the Nursing EPS Assessment Scale possessed good interrater reliability for nursing assessment of EPS.
Assuntos
Doenças dos Gânglios da Base/diagnóstico , Avaliação em Enfermagem/métodos , Variações Dependentes do Observador , Doenças dos Gânglios da Base/fisiopatologia , Hospitais de Veteranos , Humanos , Indiana , Masculino , Avaliação em Enfermagem/normas , Reprodutibilidade dos TestesRESUMO
At the time of diagnosis and after therapy, we examined 33 patients suffering from Wilson's disease. We applied a standardized diagnostic score system on the basis of clinical signs. Without observing any differences between pseudoparkinsonian and pseudosclerosis subtypes, patients with neurological symptoms significantly improved by 2.33 points. Patients with initially more severe symptoms showed the same improvement as less affected patients. Fine motor disturbances were evaluated using the V-scope system. Finger tapping and drawing a spiral were compared to values of a healthy control group (n = 52). Patients with neurological symptoms showed significantly decreased frequencies in both tests. The clinical score was related to frequencies in finger tapping but not in drawing a spiral. Therefore finger tapping can be used as an objective diagnostic tool to evaluate the severity of Wilson's disease, while spiral testing appears to be a sensitive screening tool.
Assuntos
Doenças dos Gânglios da Base/diagnóstico , Degeneração Hepatolenticular/diagnóstico , Destreza Motora , Exame Neurológico , Desempenho Psicomotor , Adulto , Gânglios da Base/fisiopatologia , Doenças dos Gânglios da Base/fisiopatologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Destreza Motora/fisiologia , Doença de Parkinson Secundária/diagnóstico , Doença de Parkinson Secundária/fisiopatologia , Transtornos Psicomotores/diagnóstico , Transtornos Psicomotores/fisiopatologia , Desempenho Psicomotor/fisiologiaRESUMO
We report a case of clinically diagnosed corticobasal degeneration, in whom neuropsychological testing was performed along with functional imaging with IBZM SPECT. HM-PAO SPECT showed marked perfusion asymmetry in parietal cortical regions, lower to the right, contralateral to the most affected side. IBZM SPECT, which gives information about postsynaptic dopaminergic D2 receptors, showed severe reduction of tracer uptake in the right basal ganglia. Our findings suggest that a postsynaptic lesion in the basal ganglia might account for the lack of response of extrapyramidal motor symptoms to dopaminergic agonists in corticobasal degeneration.